Adaptive Iterative Dose Reduction (ADIR) 3D, the third generation software, will be offered to existing Aquilion One, Premium, and Prime CT customers.
Toshiba America Medical Systems Inc.’s latest dose reduction software, Adaptive Iterative Dose Reduction (ADIR) 3D, has received FDA clearance, the company announced.
The third generation software, which Toshiba will offer to existing Aquilion One, Premium, and Prime CT customers, reduces radiation dose compared to conventional scanning, the company said. The algorithm, designed to work in raw data and imaging data space, reduces noise while attempting to maintain image quality.
The ADIR 3D can be integrated with Sure Exposure 3D, software that calculates the minimum radiation exposure required for every exam based on pre-set targeted level of image quality.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.